Leonard S. Schleifer
2010
In 2010, Leonard S. Schleifer earned a total compensation of $7.6M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 20% increase compared to previous year.
Compensation breakdown
| Bonus | $1,215,000 |
|---|---|
| Option Awards | $5,512,125 |
| Salary | $759,370 |
| Other | $101,060 |
| Total | $7,587,555 |
Schleifer received $5.5M in option awards, accounting for 73% of the total pay in 2010.
Schleifer also received $1.2M in bonus, $759.4K in salary and $101.1K in other compensation.
Rankings
In 2010, Leonard S. Schleifer's compensation ranked 554th out of 10,439 executives tracked by ExecPay. In other words, Schleifer earned more than 94.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 554 out of 10,439 | 95th |
Division Manufacturing | 194 out of 3,838 | 95th |
Major group Chemicals And Allied Products | 43 out of 921 | 95th |
Industry group Drugs | 26 out of 680 | 96th |
Industry Pharmaceutical Preparations | 22 out of 481 | 95th |
Source: SEC filing on April 26, 2013.
Schleifer's colleagues
We found three more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2010.
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019